Zusammenfassung
Anaplastisch großzellige Lymphome sind durch große, pleomorphe Zellen und starke Expressivität des Zytokinrezeptors CD30 gekennzeichnet. Wir berichten über einen 71-jährigen Patienten mit mehreren Tumorknoten im Bereich der rechten Schläfe und des rechten Ohransatzes. Anhand klinischer, histologischer und immunphänotypischer Kriterien konnte die Diagnose eines CD30(+) ALK(−) anaplastisch großzelligen primär kutanen T-Zell-Lymphoms gestellt werden. Nach lokaler Exzision der Tumorknoten und adjuvanter Radiotherapie zeigte sich in einem Follow-up von 3 Monaten kein Hinweis für ein Rezidiv.
Abstract
Anaplastic large cell lymphomas (ALCL) are characterized by large, pleomorphic cells with a strong expression of cytokine receptor CD 30. We present a 71-year-old patient with several nodules on the right temple extending to his right ear. Based on clinical, histological and immunophenotypic criteria, the diagnosis of a primary cutaneous CD30(+) ALK(−) anaplastic large cell lymphoma was made. After local excision and adjuvant radiotherapy no relapse occurred during a follow-up period of three months.
Literatur
Bekkenk MW, Geelen FA, van Voorst Vader PC et al (2000) Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653–3661
Beylot-Barry M, Groppi A, Vergier B et al (1998) Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations. Blood 91:4668
Chan JK, Ng CS, Hui PK et al (1989) Anaplastic large cell Ki-1 lymphoma: delineation of two morphological types. Histopathology 15:11
Chott A, Kaserer K, Augustin I et al (n d) Ki-1-positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol 14:439
de Bruin PC, Beljaards RC, van Heerde P et al (1993) Differences between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127
Falini B, Pileri S, Stein H et al (1990) Variable expression of leucozyte-common antigen (CD45) in CD30 (Ki-1)-positive anaplastic large cell lymphomas: implications for the differential diagnosis between lymphoid and non-lymphoid malignancies. Hum Pathol 2:624
Paulli M, Berti E, Rosso R et al (1995) CD30/Ki-1-positive lymphoproliferative disorders of the skin – clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 13:1343–1354
Rimokh R, Magaud JP, Berger F et al (1989) A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma („Ki-1 lymphoma“). Br J Haematol 7:31
Shiota M, Nakamura S, Ichinohasama R et al (1995) Anaplastic large cell lymphomas expressing the chimetric protein p80 NPM/ALK: a distinct clinico-pathologic entity. Blood 86:1954
Slater DN (2005) The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol 153:874–880
Stein H, Foss HD, Dürkop H, Marafioti T et al (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic and clinical features. Blood 96:3681–3695
Stein H, Gerdes J, Schwab U et al (1982) Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer 30:445
Vonderheid EC, Sajjadian A, Kadin ME (1996) Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutanesous CD30-positive lymphoprolifertaive disorders. J Am Acad Dermatol 34:470–481
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mühlhoff, C., Rübben, A., Gaßler, N. et al. CD30(+) ALK(−) anaplastisch großzelliges primär kutanes T-Zell-Lymphom. Hautarzt 60, 954–956 (2009). https://doi.org/10.1007/s00105-009-1874-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-009-1874-2
Schlüsselwörter
- Anaplastisch großzelliges Lymphom
- CD30(+) anaplastisch großzelliges primär kutanes Lymphom
- Anaplastische Lymphomkinase (ALK)
- Zytokinrezeptor CD30